*GG*
senior member
- Messages
- 6,394
- Location
- Concord, NH
Tuesday, June 3, 2014. On May 3, 2014, the journalMedical Science Monitor reported a benefit for intravenous vitamin C in patients with high levels of antibodies to the Epstein-Barr virus (EBV), which has been implicated in chronic fatigue syndrome, Burkett's lymphoma, Hodgkin's disease and some autoimmune conditions. "This is, to our knowledge, the first clinical study of ascorbic acid and EBV infection," announce authors Nina A. Mikirova and Ronald Hunninghake of the Riordan Clinic in Wichita.
The duo evaluated data from 35 men and women diagnosed with chronic fatigue or other conditions who had Epstein-Barr virus antibodies measured before and after treatment with 7.5 to 50 grams of intravenous vitamin C. Thirty-two of the 35 subjects showed improvement following vitamin C treatment. While the level of IgG antibodies to the EBV early diffuse antigen (EBV EA IgG) averaged 80 AU (arbitrary units) before treatment, post-treatment levels averaged 46 AU. Subjects who had five or more vitamin C infusions had a significantly greater percent decrease in EBV antibodies over time in comparison with infected individuals evaluated by the clinic who did not receive intravenous vitamin C, with EBV EA IgG levels showing a decline in association with increasing treatments.
cont'd
http://www.lef.org/newsletter/2014/...icle&utm_content=Button&utm_campaign=2014Wk18
The duo evaluated data from 35 men and women diagnosed with chronic fatigue or other conditions who had Epstein-Barr virus antibodies measured before and after treatment with 7.5 to 50 grams of intravenous vitamin C. Thirty-two of the 35 subjects showed improvement following vitamin C treatment. While the level of IgG antibodies to the EBV early diffuse antigen (EBV EA IgG) averaged 80 AU (arbitrary units) before treatment, post-treatment levels averaged 46 AU. Subjects who had five or more vitamin C infusions had a significantly greater percent decrease in EBV antibodies over time in comparison with infected individuals evaluated by the clinic who did not receive intravenous vitamin C, with EBV EA IgG levels showing a decline in association with increasing treatments.
cont'd
http://www.lef.org/newsletter/2014/...icle&utm_content=Button&utm_campaign=2014Wk18